Reuters logo
BRIEF-Abbott announces two Mitral valve transactions
2015年7月30日 / 下午3点10分 / 2 年前

BRIEF-Abbott announces two Mitral valve transactions

July 30 (Reuters) - Abbott Laboratories

* Abbott says will acquire the equity of Tendyne that it does not already own for $225 million upfront

* To purchase Tendyne holdings inc for total transaction value of $250 million, plus potential future payments

* In a separate transaction, provided capital and secured option to purchase Cephea Valve Technologies; financial terms not disclosed

* Neither Tendyne acquisition nor option to purchase Cephea expected to impact Abbott’s ongoing 2015 EPS guidance Source text for Eikon: Further company coverage: ))

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below